In a 42-year-old female with blood pressure 108/64 mm Hg, heart rate 50 bpm, BMI 29.8 kg/m², who is taking lisinopril, venlafaxine extended‑release, atorvastatin, tirzepatide (Mounjaro), paroxetine, and buspirone, and denies dizziness, what is the recommended management for her asymptomatic bradycardia?

Reassess and Potentially Adjust Medications Causing Bradycardia

In this asymptomatic 42-year-old woman with a heart rate of 50 bpm, no intervention is required, but you should evaluate her medication regimen for potential drug-drug interactions and consider whether all medications are essential, particularly focusing on the combination of venlafaxine, paroxetine, and lisinopril. 1

Key Management Principles

No Immediate Action Needed

• Asymptomatic bradycardia does not require treatment or pacing 1
• The 2018 ACC/AHA/HRS guidelines explicitly state that asymptomatic patients have no indication for permanent pacing, even with documented sinus node dysfunction, because the benefit of pacing is essentially symptom relief and quality of life improvement 1
• Since she denies dizziness, lightheadedness, syncope, or other symptoms of hypoperfusion, observation is appropriate

Medication Review is Critical

Identify the likely culprits:

1. Venlafaxine (SNRI) - Known to cause bradycardia, particularly when combined with other medications 2, 3

   • Case reports document bradycardia with venlafaxine, especially in combination with other drugs 2
   • The FDA label for venlafaxine warns about cardiovascular effects but does not specifically list bradycardia as a primary concern 4

2. Paroxetine (SSRI) - Can potentiate bradycardia when combined with venlafaxine 3

   • The combination of two serotonergic agents (venlafaxine + paroxetine) is unusual and may be contributing to the low heart rate
   • This dual SSRI/SNRI therapy warrants psychiatric consultation to determine if both are truly necessary

3. Lisinopril (ACE inhibitor) - While ACE inhibitors are not typically bradycardic, drug interactions have been reported 5

   • Generally does not cause bradycardia as monotherapy
   • However, interactions with other medications can occur 5

4. Buspirone - Minimal direct chronotropic effects but can interact with serotonergic medications 4

5. Atorvastatin - Rare reports of bradyarrhythmias exist, but typically in the context of multiorgan dysfunction or very high doses 6

   • At 10 mg daily, this is unlikely to be the primary cause

6. Tirzepatide (Mounjaro) - Not known to cause bradycardia 7, 8

   • Actually associated with modest blood pressure reductions but not heart rate effects 8

Recommended Approach

Step 1: Document the Bradycardia

• Obtain a 12-lead ECG to confirm sinus bradycardia and rule out conduction abnormalities
• Consider ambulatory monitoring (Holter or event monitor) if there's any concern about symptoms correlating with heart rate changes

Step 2: Evaluate for Reversible Causes

According to ACC/AHA/HRS guidelines, patients with symptomatic sinus node dysfunction secondary to a reversible cause should first be managed by directing therapy at eliminating or mitigating the offending condition 1

Check:

• TSH (hypothyroidism can cause bradycardia) 1
• Electrolytes, particularly potassium 1
• Renal function (affects drug clearance)
• Hepatic function (affects drug metabolism)

Step 3: Medication Optimization

The most concerning issue is the dual serotonergic therapy (venlafaxine + paroxetine):

• This combination is unusual and potentially redundant
• Consult with the prescribing psychiatrist to determine if both medications are necessary
• If both are deemed essential, consider that the combination may be contributing to bradycardia 2, 3

Consider the following hierarchy:

1. If psychiatric symptoms are well-controlled, consider tapering one of the serotonergic agents under psychiatric supervision
2. If hypertension control allows (BP is 108/64), lisinopril could be reduced or switched to a non-ACE inhibitor alternative, though this is less likely to be the primary cause
3. Continue atorvastatin at current dose (10 mg is low and unlikely causative) 6
4. Continue tirzepatide (not associated with bradycardia) 7, 8

Step 4: Monitoring Strategy

If medications cannot be adjusted:

• Educate the patient about symptoms of symptomatic bradycardia: dizziness, lightheadedness, syncope, fatigue, dyspnea on exertion 1
• Schedule follow-up in 2-4 weeks to reassess heart rate and symptoms
• Repeat vital signs at each visit
• Only if symptoms develop should you consider further intervention 1

Important Caveats

• Do not perform electrophysiology studies - These are not indicated in asymptomatic sinus bradycardia 1
• Do not consider pacing - Permanent pacing is only indicated when symptoms correlate with bradycardia and reversible causes have been excluded 1
• The combination of venlafaxine and paroxetine is the most likely modifiable factor - This dual therapy should be questioned 2, 3
• Watch for development of symptoms, particularly with exertion, as chronotropic incompetence can affect quality of life even without resting symptoms 1

When to Escalate Care

Refer to cardiology if:

• Symptoms develop (dizziness, syncope, presyncope, dyspnea)
• Heart rate drops below 40 bpm
• ECG shows conduction abnormalities beyond simple sinus bradycardia
• Medications cannot be adjusted and symptoms emerge

The key message: asymptomatic bradycardia requires observation and medication review, not intervention 1